Sherrie L. Perkins - Concepedia

Author

Sherrie L. Perkins

Also Known As

S L Perkins, SHERRIE L. PERKINS, Sherrie L Perkins, Sherrie L. Perkins, Sherrie L. Perkins, MD, PhD, Sherrie L. Perkins4, Sherrie Perkins

258

Publications

11.4K

Citations

H-Index

136

Concepts

All Affiliations

University of Utah ARUP Laboratories (United States)University of Nebraska Medical Center Columbia University ARUP Institute for Clinical and Experimental Pathology

About

Sherrie L. Perkins is an author at University of Utah specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	66	4.2K
2	Health Sciences	12	13	580
3	Public Health	2	2	102
4	Engineering	1	1	38
5	Natural Sciences	1	1	56

Sherrie L. Perkins

141

Publications

10K

Citations

H-Index

Page 1

	Year	Citations
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia Teresa Palomero, Maria Luisa Sulis, Maria S. Cortina, Nature Medicine Hematological MalignancyImmunologyT-cell LeukemiaNotch1 InhibitionAdult T-cell Leukemia-lymphoma	2007	870
ALK1 and p80 Expression and Chromosomal Rearrangements Involving 2p23 in Inflammatory Myofibroblastic Tumor Cheryl M. Coffin, Ankita Patel, Sherrie L. Perkins, Modern Pathology MedicineChromosomal RearrangementsPathologyInflammatory Myofibroblastic TumorMolecular Pathology	2001	631
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients Catherine Patte, Anne Aupérin, Mary Gerrard, Blood	2006	427
Expression of ALK1 and p80 in Inflammatory Myofibroblastic Tumor and Its Mesenchymal Mimics: A Study of 135 Cases Melissa H. Cessna, Holly Zhou, Warren G. Sanger, Modern Pathology	2002	385
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents Mitchell S. Cairo, Mary Gerrard, Richard Sposto, Blood	2006	359
Are Myogenin and MyoD1 Expression Specific for Rhabdomyosarcoma? Melissa H. Cessna, Holly Zhou, Sherrie L. Perkins, The American Journal of Surgical Pathology	2001	279
Immunohistochemical Expression Patterns of Germinal Center and Activation B-cell Markers Correlate With Prognosis in Diffuse Large B-cell Lymphoma Chung-Che Chang, Sara McClintock, Ronald P. Cleveland, The American Journal of Surgical Pathology	2004	258
Revised International Pediatric Non-Hodgkin Lymphoma Staging System Angelo Rosolen, Sherrie L. Perkins, CR Pinkerton, Journal of Clinical Oncology	2015	226
Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B‐cell non‐Hodgkin’s lymphoma: results of the FAB/LMB 96 international study* Mary Gerrard, Mitchell S. Cairo, Claire Weston, British Journal of Haematology Hematological MalignancyLymphoid NeoplasiaB NhlSurgical OncologyCopad Chemotherapy	2008	198
Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors. Jerry W. Hussong, Michael D. Brown, Sherrie L. Perkins, PubMed	1999	189

Page 1